Document is current
Any future updates will be listed below
-
Authors
Lu, Xue
He, Yaowu
Johnston, Rebecca L.
Nanayakarra, Devathri
Sankarasubramanian, Sivanandhini
Lopez, J. Alejandro
Friedlander, Michael
Kalimutho, Murugan
Hooper, John D.
Raninga, Prahlad V. http://orcid.org/0000-0003-3013-6526
Khanna, Kum Kum
-
Funding
Funding for this research was provided by:
Ovarian Cancer Research Foundation (ONBCF-20-011)
ANZGOG (ANZGOG)
- License Information
-
More Information
Article History
Received: 19 September 2022
Accepted: 12 December 2022
First Online: 21 December 2022
Declarations
:
: All experiments were conducted in accordance with the protocols approved by QIMR Berghofer Medical Research Institute Animal Ethics Committee and the University of Queensland Animal Ethics Committee.
: All authors have provided consent for the publication of this manuscript.
: M. Friedlander declares: honorariat for advisory boards AstraZeneca, GSK, Incyclix, Lilly, MSD, Novartis, Takeda; consultancy for AstraZeneca, Eisai, Novartis; speaker’s fee and travel from AstraZeneca; speaker’s fee from ACT genomics; institutional research funding from AstraZeneca, BeiGene, Novartis.All other authors declare that they have no competing interests.
